GTR 93142474
Tenders Are Invited For Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredients/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
ICB — International Competitive Bid
Closes Mar 05, 2027
Western Europe
Tender Information
GTR Reference
93142474
Tendering Authority
Subscribe to view
Tender No
125171-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredients/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
05-03-2027
Work Detail
Pharmaceutical Products-Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredients/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure. Botulinum Toxin Type A (Atc M03ax21),Dalteparin,Dutastasteride And Tamsulosine,Formoterol And Aclidinium Bromide,Glatirameracetate 40 Mg Only Finished,Guselkumab,Ibuprofen,Melatonin, Excavation. Retard Tablets With The Active Ingredient Thickness 2 Mg,Midazolam,Minoxidil,Olodaterol And Tiotropium Bromide (Atc R03al06),Opipramol,Raltegravir,Sultamicillin,Urapidil,Valproinic Acid
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
795f2fba-c0c3-4fb9-a7cb-d38a9dd3f118.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.